SCHEMBL1577576

SCHEMBL1577576

O=[N+]([O-])c1cc(Cl)ccc1-c1nc2c(F)c(F)ccc2n1CC1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
NR1H4 Q96RI1 1/20 0.39
MAPK1 P28482 2/20 0.38
ALDH1A1 P00352 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CNR2 P34972 1/20 0.36
FBP1 P09467 3/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PTGER4 P35408 1/20 0.35
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
MEN1 O00255 1/20 0.34
HSD11B1 P28845 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1483188 0.86 NR1H4 (0.51) ALOX5NR1H4MAPK1ALDH1A1L3MBTL1
SCHEMBL1577421 0.84 ALOX5 (0.43) ALOX5NR1H4CNR2FBP1PTGER4
SCHEMBL1577569 0.83 ALOX5 (0.43) ALOX5NR1H4CNR2FBP1PTGER4
SCHEMBL1577608 0.83 ALOX5 (0.42) ALOX5NR1H4CNR2FBP1PTGER4
SCHEMBL1577428 0.83 ALOX5 (0.41) ALOX5NR1H4CNR2FBP1PTGER4
SCHEMBL1577202 0.81 ALOX5 (0.43) ALOX5NR1H4SMN1; SMN2PTGER4MAPT
SCHEMBL1577245 0.80 SLC6A4 (0.41) ALOX5NR1H4
SCHEMBL1577541 0.80 SLC6A4 (0.41) ALOX5NR1H4
SCHEMBL1577251 0.80 CRHR1 (0.41) ALOX5NR1H4FBP1SMN1; SMN2PTGER4
SCHEMBL1577164 0.79 SLC6A4 (0.40) ALOX5NR1H4FBP1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483247-A1 NEW BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2012-08-08 EP disclosed
WO-2011039130-A1 NEW BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-04-07 WO disclosed